Healthcare [ 6/13 ] | Medical Instruments & Supplies [ 130/159 ]
NASDAQ | Common Stock
| Reported Date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Apr 25, 24 | 1.5 Increased by +21.95% | 1.41 Increased by +6.38% |
| Jan 23, 24 | 1.6 Increased by +30.08% | 1.48 Increased by +8.11% |
| Oct 19, 23 | 1.46 Increased by +22.69% | 1.41 Increased by +3.55% |
| Jul 20, 23 | 1.42 Increased by +24.56% | 1.33 Increased by +6.77% |
| Apr 18, 23 | 1.23 Increased by +8.85% | 1.2 Increased by +2.5% |
| Jan 24, 23 | 1.23 Decreased by -5.38% | 1.25 Decreased by -1.6% |
| Oct 18, 22 | 1.19 Increased by 0% | 1.12 Increased by +6.25% |
| Jul 21, 22 | 1.14 Decreased by -12.98% | 1.19 Decreased by -4.2% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 24 | 1.89 B Increased by +11.46% | 544.9 M Increased by +53.36% | Increased by +28.82% Increased by +37.59% |
| Dec 31, 23 | 1.93 B Increased by +16.51% | 606.2 M Increased by +86.58% | Increased by +31.44% Increased by +60.14% |
| Sep 30, 23 | 1.74 B Increased by +11.96% | 415.7 M Increased by +28.3% | Increased by +23.84% Increased by +14.59% |
| Jun 30, 23 | 1.76 B Increased by +15.36% | 420.8 M Increased by +36.71% | Increased by +23.96% Increased by +18.51% |
| Mar 31, 23 | 1.7 B Increased by +14.01% | 355.3 M Decreased by -2.82% | Increased by +20.95% Decreased by -14.76% |
| Dec 31, 22 | 1.66 B Increased by +6.73% | 324.9 M Decreased by -14.63% | Increased by +19.63% Decreased by -20.01% |
| Sep 30, 22 | 1.56 B Increased by +10.98% | 324 M Decreased by -14.85% | Increased by +20.8% Decreased by -23.27% |
| Jun 30, 22 | 1.52 B Increased by +3.97% | 307.8 M Decreased by -40.49% | Increased by +20.22% Decreased by -42.76% |
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.